Identity
- Security key
- 20181
- Ticker
- PLRX
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2020-06-03
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- PLRX
Detail
Enriched 2026-08-14 20:47
- Market cap
- $66,256,429.79
- Shares outstanding (class)
- 61,920,249
- Shares outstanding (weighted)
- 61,921,897
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 49
- Location
- SOUTH SAN FRANCISCO, CA
- Homepage
- https://www.pliantrx.com
- Description
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Market cap and share counts drift.